Trxade Group Inc
TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.
Trxade Group Inc (MEDS) - Net Assets
Latest net assets as of June 2024: $11.79 Million USD
Based on the latest financial reports, Trxade Group Inc (MEDS) has net assets worth $11.79 Million USD as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($14.85 Million) and total liabilities ($3.06 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $11.79 Million |
| % of Total Assets | 79.37% |
| Annual Growth Rate | 26.73% |
| 5-Year Change | -86.9% |
| 10-Year Change | -18.86% |
| Growth Volatility | 332.14 |
Trxade Group Inc - Net Assets Trend (2006–2023)
This chart illustrates how Trxade Group Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Trxade Group Inc (2006–2023)
The table below shows the annual net assets of Trxade Group Inc from 2006 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $542.35K | +58.18% |
| 2022-12-31 | $342.87K | -90.91% |
| 2021-12-31 | $3.77 Million | -56.56% |
| 2020-12-31 | $8.68 Million | +109.63% |
| 2019-12-31 | $4.14 Million | +390.16% |
| 2018-12-31 | $844.67K | +370.79% |
| 2017-12-31 | $-311.93K | +72.83% |
| 2016-12-31 | $-1.15 Million | -529.96% |
| 2015-12-31 | $267.02K | -60.05% |
| 2014-12-31 | $668.44K | +410.79% |
| 2013-12-31 | $130.87K | +648.53% |
| 2012-12-31 | $17.48K | +100.04% |
| 2008-12-31 | $-48.01 Million | -259231.28% |
| 2007-12-31 | $-18.51K | -291.39% |
| 2006-12-31 | $9.67K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Trxade Group Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3323651300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $9.00 | 0.00% |
| Other Components | $33.79 Million | 6229.94% |
| Total Equity | $542.35K | 100.00% |
Trxade Group Inc Competitors by Market Cap
The table below lists competitors of Trxade Group Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Datasea Inc
NASDAQ:DTSS
|
$5.54 Million |
|
Rubicon Water Ltd
AU:RWL
|
$5.54 Million |
|
SUNEX S.A.
WAR:SNX
|
$5.54 Million |
|
Stock Trend Capital Inc.
PINK:STOCF
|
$5.54 Million |
|
Immo Moury SICAF Immobiliere Publique de Droit Belge
BR:IMMOU
|
$5.54 Million |
|
SportsHero Limited
PINK:NIROF
|
$5.54 Million |
|
Immo Mcc NV
BR:MCC
|
$5.54 Million |
|
Rockhaven Resources Ltd
PINK:RKHNF
|
$5.53 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Trxade Group Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 763,136 to 542,353, a change of -220,783 (-28.9%).
- Net loss of 17,843,574 reduced equity.
- Other factors increased equity by 17,622,791.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-17.84 Million | -3290.03% |
| Other Changes | $17.62 Million | +3249.32% |
| Total Change | $- | -28.93% |
Book Value vs Market Value Analysis
This analysis compares Trxade Group Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 33.11x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 63.29x to 33.11x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-12-31 | $0.12 | $7.54 | x |
| 2007-12-31 | $-0.18 | $7.54 | x |
| 2008-12-31 | $-453.95 | $7.54 | x |
| 2012-12-31 | $0.11 | $7.54 | x |
| 2013-12-31 | $0.84 | $7.54 | x |
| 2014-12-31 | $2.02 | $7.54 | x |
| 2015-12-31 | $0.76 | $7.54 | x |
| 2016-12-31 | $-3.28 | $7.54 | x |
| 2017-12-31 | $-0.82 | $7.54 | x |
| 2018-12-31 | $2.17 | $7.54 | x |
| 2019-12-31 | $10.47 | $7.54 | x |
| 2020-12-31 | $16.90 | $7.54 | x |
| 2021-12-31 | $6.95 | $7.54 | x |
| 2022-12-31 | $1.35 | $7.54 | x |
| 2023-12-31 | $0.23 | $7.54 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Trxade Group Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -3290.03%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -215.70%
- • Asset Turnover: 0.66x
- • Equity Multiplier: 23.11x
- Recent ROE (-3290.03%) is below the historical average (-484.80%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | -90.20% | 0.00% | 0.00x | 1.36x | $-9.69K |
| 2007 | 0.00% | 0.00% | 0.00x | 0.00x | $-26.33K |
| 2008 | 0.00% | 0.00% | 0.00x | 0.00x | $-23.70 Million |
| 2012 | -862.05% | -18.70% | 6.79x | 6.79x | $-152.46K |
| 2013 | -1598.05% | -218.78% | 2.37x | 3.09x | $-2.10 Million |
| 2014 | -301.01% | -134.47% | 1.22x | 1.83x | $-2.08 Million |
| 2015 | -418.39% | -22.38% | 2.46x | 7.59x | $-1.14 Million |
| 2016 | 0.00% | -111.21% | 7.36x | 0.00x | $-2.65 Million |
| 2017 | 0.00% | 9.86% | 4.75x | 0.00x | $320.18K |
| 2018 | 1.07% | 0.24% | 1.72x | 2.64x | $-75.43K |
| 2019 | -9.90% | -5.51% | 1.33x | 1.35x | $-823.75K |
| 2020 | -29.56% | -14.98% | 1.75x | 1.13x | $-3.43 Million |
| 2021 | -109.09% | -41.59% | 1.72x | 1.53x | $-4.49 Million |
| 2022 | -564.80% | -37.65% | 3.09x | 4.86x | $-4.39 Million |
| 2023 | -3290.03% | -215.70% | 0.66x | 23.11x | $-17.90 Million |
Industry Comparison
This section compares Trxade Group Inc's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $239,198,060
- Average return on equity (ROE) among peers: -6.39%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Trxade Group Inc (MEDS) | $11.79 Million | -90.20% | 0.26x | $5.54 Million |
| Alibaba Health Information Technology Limited (ALBBY) | $1.12 Billion | -18.54% | 0.50x | $12.50 Billion |
| Allstar Health Brands Inc (ALST) | $-9.92 Million | 0.00% | 0.00x | $3.83 |
| Bimi International Medical Inc (BIMI) | $-409.66K | 0.00% | 0.00x | $296.83 |
| Blum Holdings Inc (BLMH) | $-4.74 Million | 0.00% | 0.00x | $8.97 Million |
| China Jo-Jo Drugstores Inc (CJJD) | $26.66 Million | -21.17% | 1.52x | $5.94 Million |
| Clicks Group Ltd (CLCGY) | $1.13 Billion | 41.98% | 2.72x | $4.80 Billion |
| China BCT Pharmacy Group Inc (CNBI) | $134.27 Million | 15.68% | 0.82x | $0.96 |
| Dalrada Financial Corp (DFCO) | $4.40 Million | -81.82% | 0.55x | $1.57 Million |
| Health Advance Inc (HADV) | $-105.34K | 0.00% | 0.00x | $25.40K |
| Healthwarehouse.Com (HEWA) | $-3.10 Million | 0.00% | 0.00x | $720.96 |